Multiple roles for the Wilms' tumour suppressor gene, WT1 in genitourinary development

Molecular and Cellular Endocrinology

Volumn 140, Issue 1-2, 1998, Pages 65-69

  Schedl, Andreas ^a   Hastie, Nicholas ^b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Genitourinary development; WAGR syndrome; Wilm's tumour

Indexed keywords

TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; CANCER GENETICS; CANCER SUSCEPTIBILITY; CHILDHOOD CANCER; CHROMOSOME DELETION; CONFERENCE PAPER; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENE MUTATION; GENETIC PREDISPOSITION; GONAD DEVELOPMENT; GONADAL DYSGENESIS; HUMAN; HUMAN CELL; KIDNEY CANCER; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KNOCKOUT MOUSE; MOUSE; NEPHROBLASTOMA; NONHUMAN; OVARY DEVELOPMENT; PRIORITY JOURNAL; TESTIS DEVELOPMENT; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UROGENITAL SYSTEM;

ANIMALS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENES, WILMS TUMOR; GENITALIA; GONADAL DYSGENESIS; HUMANS; MALE; MUTATION; TRANSCRIPTION FACTORS; URINARY TRACT; WILMS TUMOR; WT1 PROTEINS;

EID: 0032565736     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00031-8     Document Type: Conference Paper

References (35)

1. Armstrong J.F., Pritchard-Jones K., Bickmore W.A., Hastie N.D., Bard J.B.L. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech. Dev. 40:1992;85-97.
2. Bickmore W.A., Oghene K., Little M.H., Seawright A., Van Heyningen V., Hastie N.D. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. Science. 257:1992;235-237.
3. Bruening W., Pelletier J. A non-AUG translational initiation event generates novel WT1 isoforms. J. Biol. Chem. 271:1996;8646-8654.
4. Bruening W., Bardeesy N., Silverman B.L., Cohn R.A., Machin G.A. et al. Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development. Nat. Genet. 1:1992;144-148.
5. Call K.M., Glaser T., Ito C.Y., Buckler A.J., Pelletier J., Haber D.A., Rose E.A., Kral A., Yeger H., Lewis W.H., Jones C., Housman D.E. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell. 60:1990;509-520.
6. Caricasole A., Duarte A., Larsson S., Hastie N.D., Little M., Holmes G., Todorov I., Ward A. RNA binding by the Wilms' tumour suppressor (WT1) zinc finger proteins. Proc. Natl. Acad. Sci. USA. 93:1996;7562-7566.
7. Coppes M.J., Liefers G.J., Paul P., Yeger H., Williams B.R.G. Homozygous somatic WT1 point mutations in sporadic unilateral Wilms tumor. Proc. Natl. Acad. Sci. USA. 90:1993;1416-1419.
8. Drummond I.A., Madden S.L., Rohwer-Nutter P., Bell G.I., Sukhatme V.P., Rauscher F.J. III Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science. 257:1992;674-678.
9. Drummond I.A., Rupprecth H.D., Rohwer-Nutter P., Lopez-Guisa J., Madden S.L. et al. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1. Mol. Cell. Biol. 14:1994;3800-3809.
10. Englert C., Hou X., Maheswaran S., Bennett P., Ngwu C., Re G.G., Garvin A.J., Rosner M.R., Haber D.A. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 14:1995a;4462-4675.
11. Gashler A.J., Bonthron D.T., Madden S.L., Rauscher F.J. III, Collins T., Sukhatme V.P. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc. Natl. Acad. Sci. USA. 89:1992;10984-10988.
12. Gessler M., Pustka A., Cavenee W., Neve R.L., Orkin S.H., Bruns G.A.P. Homozygous deletion in Wilms' tumours of a zinc finger gene identified by chromosome jumping. Nature. 343:1990;774-778.
13. Gessler M., Konig A., Arden K., Grundy P., Orkin S. et al. Infrequent mutation of the WT1 gene in 77 Wilms' tumors. Hum. Mutat. 3:1994;212-222.
14. Haber D.A., Buckler A.J., Glaser T., Call K.M., Pelletier J. et al. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell. 61:1990;1257069.
15. Haber D.A., Sohn R.L., Buckler A.J., Pelletier J., Call K.M., Housman D.E. Alternative splicing and genomic structure of the Wilms' tumor gene WT1. Proc. Natl. Acad. Sci. USA. 88:1991;9618-9622.
16. Harrington M.A., Konicek B., Song A., Xia X., Fredericks W.J., Rauscher F.J. III Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus. J. Biol. Chem. 268:1993;21271-21275.
17. Hastie, N.D., 1994. The genetics of Wilms' tumor - a case of disrupted development. Annu. Rev. Genet. 523-558.
18. Kennedy D., Ramsdale T., Mattick J., Little M. An RNA recognition motif in WT1 revealed by structural modelling. Nat. Genet. 12(3):1996;329-332.
19. Kreidberg J.A., Sariola H., Loring J.M, Maeda M., Pelletier J. et al. WT1 is required for early kidney development. Cell. 74:1993;679-691.
20. Larsson S.H., Charlieu J.-P., Miyagawa K., Engelkamp D., Ross A., Van Heyningen V., Hastie N.D. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell. 81:1995;391-401.
21. Little M.H., Prosser J., Condie A., Smith P.J., Van Heyningen V., Hastie N.D. Zinc finger point mutations within the WT1 gene in tumour patients. Proc. Natl. Acad. Sci. 89:1992;4791-4795.
22. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell. 77:1994;481-490.
23. Madden S.L., Cook D.M., Morris J.F., Gashler A., Sukhatme V.P., Rauscher F.J. III. Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science. 253:1991;1550-1553.
24. Mundlos S., Pelletier J., Darveau A., Bachmann M., Winterpacht A., Zabel B. Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development. 119:1993;1329-1341.
25. Park S., Schalling M., Bernard A., Maheswaran S., Shipley G.C. et al. The Wilms' tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mosothelioma. Nat. Genet. 4:1993;415-420.
26. Pavletich N.P., Pabo C.O. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1A. Science. 252:1991;809-817.
27. Pelletier J., Bruening W., Li F.P., Haber D.A., Glaser T., Housman D.E. WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour. Nature. 353:1991a;431-434.
28. Pelletier J., Bruening W., Kashtan C.E., Mauer S.M., Manivel J.C. et al. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys Drash syndrome. Cell. 67:1991b;437-447.
29. Pritchard-Jones K., Fleming S., Davidson D., Bickmore W., Porteous D.J. et al. The candidate Wilms' tumour gene is involved in genitourinary development. Nature. 346:1990;194-197.
30. Rauscher F.J., Morris J.F., Tournay O.E., Cook D.M., Curran T. Binding of the Wilms' tumor locus zinc finger protein to the EGR-consensus sequence. Science. 250:1990;1259-1262.
31. Reddy J.C et al. WT1-mediated transcriptional activation is inherited by dominant negative mutant proteins. J. Biol. Chem. 270:1995;10878-10884.
32. Ryan G., Steele Perkins V., Morris J.F., Rauscher F.J., Dressler G.R. Repression of Pax-2 by WT1 during normal kidney development. Development. 121:1995;867-875.
33. Sharma P.M., Bowman M., Madden S.L., Rauscher F.J., Sukumar S.L. RNA editing in the Wilms' tumor susceptibility gene, WT1. Genes Dev. 8:1994;720-731.
34. Van Heyningen V., Bickmore W.A., Seawright A., Fletcher J.M., Maule J. et al. Role of the Wilms' tumor gene in genital development? Proc. Natl. Acad. Sci. USA. 87:1990;5383-5386.
35. Wang Z.Y., Qui Q.Q., Deuel T.F. The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains. J. Biol. Chem. 268(13):1993;9172-9175.